Premal H Thaker

8PUBLICATIONS
80CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 22, 2026
Signaling Under Stress: Targeting the Glucocorticoid Receptor in Cancer.

|Jul 22, 2025
Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response.

Mark C Valentine, Mary M Mullen, Emilee N Kotnik

|Jul 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.

Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian

|Sep 07, 2024
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study.

Premal H Thaker, Tirza Areli Calderón Boyle, Sara Burns

|Aug 01, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins.

Angela M Schab, Molly M Greenwade, Elizabeth Stock

|Apr 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer.

Amanda J Compadre, Lillian N van Biljon, Mark C Valentine

Pageof 2

Frequent Collaborators

3 joint publications

Carolyn K McCourt

3 joint publications

David G Mutch

3 joint publications

Lindsay M Kuroki

3 joint publications

Mary M Mullen